Abstract
The efficacy as well as short- and long-term safety of metformin in women with gestational diabetes mellitus have been constantly confirmed in recent years. Metformin could decrease the weight gain during pregnancy and the incidence of hypoglycemia compared with insulin, without increasing the incidence of adverse pregnant outcomes. Moreover, no significant adverse outcome has been found in the offspring of women treated with metformin in pregnancy. This article reviews the evidence for efficacy and safety of using metformin during pregnancy, summarizes the latest guidelines and recommendations, and describes the specific medication regimen. Key words: Metformin; Diabetes, gestational; Validation studies; Clinical protocols
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
